{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:53:17Z","timestamp":1773406397436,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.jpeds.2010.02.042","type":"journal-article","created":{"date-parts":[[2010,4,19]],"date-time":"2010-04-19T04:48:58Z","timestamp":1271652538000},"page":"282-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["The Efficacy and Safety of the Novel Aldosterone Antagonist Eplerenone in Children with Hypertension: A Randomized, Double-Blind, Dose-Response Study"],"prefix":"10.1016","volume":"157","author":[{"given":"Jennifer S.","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph T.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Portman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayo","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milton L.","family":"Pressler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2010.02.042_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1058-9813(00)00071-0","article-title":"Evaluation and management of hypertension in childhood","volume":"12","author":"Flynn","year":"2001","journal-title":"Prog Pediatr Cardiol"},{"key":"10.1016\/j.jpeds.2010.02.042_bib2","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1001\/jama.288.14.1728","article-title":"Prevalence and trends in overweight among US children and adolescents, 1999-2000","volume":"288","author":"Ogden","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2010.02.042_bib3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1542\/peds.84.4.633","article-title":"Childhood risk factors for high adult blood pressure: the Muscatine Study","volume":"84","author":"Lauer","year":"1989","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2010.02.042_bib4","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM199806043382302","article-title":"Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study","volume":"338","author":"Berenson","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2010.02.042_bib5","first-page":"189","article-title":"Trials of antihypertensive therapies in children","volume":"4","author":"Wells","year":"1999","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.jpeds.2010.02.042_bib6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1542\/peds.2007-1529","article-title":"Improving pediatric dosing through pediatric initiatives: what we have learned","volume":"121","author":"Rodriguez","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2010.02.042_bib7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension","volume":"15","author":"Weinberger","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jpeds.2010.02.042_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/01.HYP.0000025146.19104.FE","article-title":"Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients","volume":"40","author":"Krum","year":"2002","journal-title":"Hypertension"},{"issue":"Suppl","key":"10.1016\/j.jpeds.2010.02.042_bib9","first-page":"555","article-title":"The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents","volume":"114","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2010.02.042_bib10","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1542\/peds.111.6.1416","article-title":"National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification","volume":"111","author":"Hogg","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2010.02.042_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/clc.20324","article-title":"A comparison of the aldosterone-blocking agents eplerenone and spironolactone","volume":"31","author":"Struthers","year":"2008","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jpeds.2010.02.042_bib12","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0735-1097(03)00054-8","article-title":"Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients","volume":"41","author":"Flack","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jpeds.2010.02.042_bib13","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2215\/CJN.00240106","article-title":"Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes","volume":"1","author":"Epstein","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jpeds.2010.02.042_bib14","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-Left Ventricular Hypertrophy Study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2010.02.042_bib15","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/S0149-2918(03)80282-5","article-title":"Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension","volume":"25","author":"Burgess","year":"2003","journal-title":"Clin Ther"},{"issue":"2 Pt 2","key":"10.1016\/j.jpeds.2010.02.042_bib16","doi-asserted-by":"crossref","first-page":"57S","DOI":"10.1016\/S0895-7061(01)02303-2","article-title":"Prevalence and consequence of systolic hypertension in children","volume":"15","author":"Sorof","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jpeds.2010.02.042_bib17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0002-8703(02)00130-8","article-title":"Oral antihypertensive trial design and analysis under the pediatric exclusivity provision","volume":"144","author":"Pasquali","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.jpeds.2010.02.042_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mce.2005.08.004","article-title":"Stimulation of testosterone production in rat Leydig cells by aldosterone is mineralocorticoid receptor mediated","volume":"243","author":"Ge","year":"2005","journal-title":"Mol Cell Endocrinol"},{"issue":"1B","key":"10.1016\/j.jpeds.2010.02.042_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0022-4731(89)90169-6","article-title":"Antialdosterones: incidence and prevention of sexual side effects","volume":"32","author":"de Gasparo","year":"1989","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.jpeds.2010.02.042_bib20","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines","volume":"117","author":"Guo","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2010.02.042_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/hr.2009.29","article-title":"Effects of epleternone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension","volume":"32","author":"Takeda","year":"2009","journal-title":"Hypertens Res"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347610001666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347610001666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:52:01Z","timestamp":1758358321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347610001666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0022347610001666"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2010.02.042","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Efficacy and Safety of the Novel Aldosterone Antagonist Eplerenone in Children with Hypertension: A Randomized, Double-Blind, Dose-Response Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2010.02.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}